DEF 14A: National Research Corporation Announces Annual Meeting of Shareholders, Executive Compensation and Director Nominees

National Research Corporation's proxy statement details the agenda for the upcoming annual shareholder meeting, including director elections, auditor ratification, and an advisory vote on executive compensation.

Summary

• National Research Corporation (NRC Health) has announced its Annual Meeting of Shareholders to be held virtually on May 8, 2024.
• Shareholders will vote on the election of two directors, ratification of KPMG LLP as the independent auditor, and an advisory vote on executive compensation.
• The record date for determining shareholders eligible to vote is March 20, 2024.
• The proxy statement provides details on corporate governance, director and executive compensation, and related matters.
• The Board recommends voting for the director nominees, ratification of the auditor, and approval of the executive compensation.
• The company's bylaws require directors to be elected by a majority of votes cast in an uncontested election.
• The Board has determined that Donald M. Berwick, Parul Bhandari, Stephen H. Lockhart, John N. Nunnelly, and Penny A. Wheeler are independent directors.
• The Compensation and Talent Committee did not engage a compensation consultant in 2023 and does not use a peer group given the absence of any publicly traded peers.
• Overall revenue declined by 2.0% in 2023 over 2022, while net income declined by 2.6%, therefore no bonuses were earned by or paid to our Named Executive Officers for 2023.
• The company's Clawback Policy allows for the recovery of incentive-based compensation in certain circumstances, such as financial restatements due to misconduct.
• In 2024, the Compensation and Talent Committee granted performance-based options to Mr. Hays and Ms. Hrdy.
• Mr. Karas will receive one year of base salary continuation payments from April 1, 2024 through March 31, 2025.

Sentiment

Score: 5

Explanation: The document presents a mix of positive and negative information, with declines in revenue and net income offset by corporate governance measures and executive compensation adjustments. The sentiment is neutral overall.

Positives

• The company has a Clawback Policy in place to recover incentive-based compensation in certain situations.
• The Board is composed of a majority of independent directors.
• The company provides a 401(k) plan for associates, matching 25% of the first 6% of compensation contributed.
• The company is committed to diversity and inclusion, as reflected in the Board Diversity Matrix.

Negatives

• Overall revenue declined by 2.0% in 2023 over 2022.
• Net income declined by 2.6% in 2023 over 2022.
• No bonuses were earned by or paid to the Named Executive Officers for 2023 due to the decline in revenue and net income.

Risks

• The company's performance is dependent on its ability to achieve growth in revenue and net income.
• Failure to attract and retain qualified executive officers could negatively impact the company's performance.
• The company faces risks related to data privacy, information security, and cybersecurity, which are overseen by the Audit Committee.

Future Outlook

The company has adopted a three-year strategic growth plan, and the Compensation and Talent Committee approved compensation packages for certain executive officers in connection with this plan.

Industry Context

The document does not provide specific details on how this announcement relates to broader industry trends or competitors.

Management Changes

Stakeholder Impact

• Shareholders are asked to vote on key proposals, including director elections and executive compensation.
• Executive officers' compensation is linked to the company's financial performance, aligning their interests with shareholders.
• The company's performance impacts employees through compensation and benefits programs.

Next Steps

• Shareholders are encouraged to vote on the proposals outlined in the proxy statement.
• The Board will consider the outcome of the advisory vote on executive compensation in future compensation decisions.
• The company will hold its Annual Meeting of Shareholders on May 8, 2024.

Key Dates

Keywords

executive compensation, annual meeting, directors, proxy statement, corporate governance, KPMG, shareholders, NRC Health